AU3144993A - Fluorophore-assisted therapeutic drug monitoring - Google Patents

Fluorophore-assisted therapeutic drug monitoring

Info

Publication number
AU3144993A
AU3144993A AU31449/93A AU3144993A AU3144993A AU 3144993 A AU3144993 A AU 3144993A AU 31449/93 A AU31449/93 A AU 31449/93A AU 3144993 A AU3144993 A AU 3144993A AU 3144993 A AU3144993 A AU 3144993A
Authority
AU
Australia
Prior art keywords
fluorophore
therapeutic drug
drug monitoring
assisted therapeutic
assisted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU31449/93A
Inventor
John C. Klock
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glyko Inc
Original Assignee
Glyko Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glyko Inc filed Critical Glyko Inc
Publication of AU3144993A publication Critical patent/AU3144993A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N31/00—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods
    • G01N31/22—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods using chemical indicators
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU31449/93A 1991-11-21 1992-11-20 Fluorophore-assisted therapeutic drug monitoring Abandoned AU3144993A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79572691A 1991-11-21 1991-11-21
US795726 1991-11-21

Publications (1)

Publication Number Publication Date
AU3144993A true AU3144993A (en) 1993-06-15

Family

ID=25166288

Family Applications (1)

Application Number Title Priority Date Filing Date
AU31449/93A Abandoned AU3144993A (en) 1991-11-21 1992-11-20 Fluorophore-assisted therapeutic drug monitoring

Country Status (3)

Country Link
EP (1) EP0641438A1 (en)
AU (1) AU3144993A (en)
WO (1) WO1993010450A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992011531A1 (en) * 1990-12-22 1992-07-09 Glyko, Inc. Analysis of carbohydrates using 2-aminoacridone
US7056504B1 (en) 1998-08-27 2006-06-06 Massachusetts Institute Of Technology Rationally designed heparinases derived from heparinase I and II
US6291439B1 (en) * 1998-09-02 2001-09-18 Biomarin Pharmaceuticals Methods for diagnosing atherosclerosis by measuring endogenous heparin and methods for treating atherosclerosis using heparin
AU4351201A (en) 2000-03-08 2001-09-17 Massachusetts Inst Technology Heparinase iii and uses thereof
PT1319183E (en) 2000-09-12 2009-06-29 Massachusetts Inst Technology Methods and products related to low molecular weight heparin
US7709461B2 (en) 2000-10-18 2010-05-04 Massachusetts Institute Of Technology Methods and products related to pulmonary delivery of polysaccharides
ES2498369T3 (en) 2002-04-16 2014-09-24 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw. A marker to measure liver cirrhosis
CN113189186A (en) * 2021-05-06 2021-07-30 湖北中医药大学 Method for detecting atherosclerosis degree by utilizing endogenous heparin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8714270D0 (en) * 1987-06-18 1987-07-22 Williams G R Analysis of carbohydrates
DE3912046B4 (en) * 1988-09-02 2004-03-25 Carnegie Mellon University Method of labeling a component of an aqueous liquid and luminescent photostable reaction product
JPH05500563A (en) * 1989-09-27 1993-02-04 アストロスキャン・リミテッド Carbohydrate analysis
US5019231A (en) * 1990-02-16 1991-05-28 Glycomed, Incorporated Electro-blotting of electrophoretically resolved fluroescent-labeled saccharides and detection of active structures with protein probes

Also Published As

Publication number Publication date
EP0641438A1 (en) 1995-03-08
WO1993010450A1 (en) 1993-05-27

Similar Documents

Publication Publication Date Title
AU4227793A (en) Drug infuser
AU2263692A (en) Multiple pharmaceutical syringe
AU626784B3 (en) Infusion alarm system
AU8723191A (en) Steerable medical device
AU2051992A (en) Syringe sprayer
AU6534894A (en) Drug administration system
AU8557591A (en) Medical device
AU3942393A (en) Steerable medical device
AU1055292A (en) Injectable medical device
AU3888793A (en) Novel medicament
AU3050492A (en) Implantable infusion device
IL103303A0 (en) Medicament
EP0567653A4 (en) Drug for hepatic diseases
AU8893291A (en) Medical electrode assembly
AU1330392A (en) Safety syringe
EP0722721A4 (en) Food-like drug
AU660290B2 (en) Multiple drug delivery system
AU4918790A (en) Medicament
AU3144993A (en) Fluorophore-assisted therapeutic drug monitoring
AU1189392A (en) Pharmaceutical agent
AU7719791A (en) Therapeutic product
AU4045489A (en) Silver sulfadiazine containing pharmaceutical product for the local external therapy
AU1740292A (en) Triphenylethylene derivative and pharmaceutical preparation containing the same
AU7502194A (en) Medication administration apparatus
AU8614291A (en) Device for administering drugs